Brief report of biweekly pemetrexed and gemcitabine in elderly patients with non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 4, Issue 9, 2009, Pages 1170-1173

  Sequist, Lecia V ^a   Fidias, Panos ^a   Heist, Rebecca S ^a   Ostler, Patricia ^a   Muzikansky, Alona ^b   Lynch, Thomas J ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c YALE CANCER CENTER   (United States)

Author keywords

Elderly; Gemcitabine; Non small cell lung cancer; Pemetrexed

Indexed keywords

CYANOCOBALAMIN; DEXAMETHASONE; FOLIC ACID; GEMCITABINE; PEMETREXED;

ADVANCED CANCER; AGED; ANEMIA; ANOREXIA; ANXIETY; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER GROWTH; CELLULITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONFUSION; CONSTIPATION; COUGHING; DEHYDRATION; DIARRHEA; DIZZINESS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; FEVER; HEAD LACERATION; HEART ATRIUM FIBRILLATION; HEMOPTYSIS; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; HYPOTENSION; HYPOXIA; INFECTION; INSOMNIA; LACERATION; LUNG ADENOCARCINOMA; LUNG EMBOLISM; MALE; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PAIN; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RESPIRATORY FAILURE; SIDE EFFECT; UROSEPSIS; WEAKNESS;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUTAMATES; GUANINE; HUMANS; LUNG NEOPLASMS; MALE;

EID: 69549089886     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181b28efe     Document Type: Article

References (15)

1. Gridelli C. The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study. Oncologist 2001;6(Suppl 1):4-7. (Pubitemid 32155180)
2. Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004;22:330-353.
3. Adjei AA, Erlichman C, Sloan JA, et al. Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors. J Clin Oncol 2000;18:1748-1757. (Pubitemid 30220554)
4. Dudek AZ, Larson T, McCleod MJ, et al. Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer. J Thorac Oncol 2008;3:394-399.
5. Blakely LJ, Schwartzberg L, Keaton M, et al. A phase II trial of pemetrexed and gemcitabine as first line therapy for poor performance status and/or elderly patients with stage IIIB/IV non-small cell lung cancer. Lung Cancer 2009 Jan 21 epub ahead of print. PMID 19167130.
6. Peacock NW, Spigel D, Hainsworth J, et al. A phase II trial of biweekly pemetrexed (P) and gemcitabine (G) in the first-line treatment (tx) of patients (pts) with advanced non-small cell lung cancer (NSCLC). Paper presented at the American Society of Clinical Oncology, Atlanta, GA, 2006.
7. Monnerat C, Le Chevalier T, Kelly K, et al. Phase II study of pemetrexed- gemcitabine combination in patients with advanced-stage non-small cell lung cancer. Clin Cancer Res 2004;10:5439-5446. (Pubitemid 39100481)
8. Ma CX, Nair S, Thomas S, et al. Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer. J Clin Oncol 2005;23:5929-5937. (Pubitemid 46300209)
9. Treat J, Bonomi P, McCleod M, et al. Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial. Lung Cancer 2006;53:77-83. (Pubitemid 43831365)
10. West HL, Wakelee HA, Perry MC, Belt RJ, Chen R, Obasaju C. Gemcitabine and pemetrexed administered in rapid sequence as frontline chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial. Ann Oncol 2009;20:850-856.
11. Gridelli C, Aapro M, Ardizzoni A, et al. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. J Clin Oncol 2005;23:3125-3137. (Pubitemid 46224136)
12. Ramalingam SS, Dahlberg SE, Langer CJ, et al. Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599. J Clin Oncol 2008;26:60-65.
13. Gridelli C, Perrone F, Gallo C, et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 2003;95:362-372. (Pubitemid 36395256)
14. Comella P, Frasci G, Carnicelli P, et al. Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients. Br J Cancer 2004;91:489-497. (Pubitemid 39093568)
15. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-3551.